{"id":209377,"name":"GLOBAL ANTIBIOTIC RESEARCH AND DEVELOPMENT PARTNERSHIP (GARDP)","slug":"global-antibiotic-research-and-development-partnership-gardp","state":null,"country":"Switzerland","description":"GARDP is a not-for-profit focused on developing treatments for drug-resistant infections.","totalSpending":60000,"filings":4,"yearlySpending":[{"year":2021,"income":60000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["FAEGRE DRINKER BIDDLE & REATH LLP"],"lobbyists":["JODIE CURTIS","LAURA HANEN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Drug resistance and antibiotic development.","FY22 appropriations regarding antibiotic research and development.","Antimicrobial resistance; antibiotic research and development.","FY 2022 appropriations regarding antibiotic research and development.","Antimicrobial resistance; Antibiotic research and development; Pandemic preparedness as it relates to antimicrobial resistance; S. 2076, H.R. 3932 - PASTEUR Act; H.R. 2036 - Saving Us from Pandemic Er"]}